期刊文献+

如何看待支气管舒张试验在诊断慢性阻塞性肺疾病中的作用 被引量:11

原文传递
导出
摘要 支气管舒张试验是应用一定剂量的舒张支气管药物使狭窄的支气管舒张,以测定其舒张程度的肺功能试验,临床上常用于判断气流受限的可逆程度,亦称为“可逆试验”。由于支气管舒张试验的安全性好,作为判断气道阻塞可逆性的客观指标,对于支气管哮喘(简称哮喘)、COPD等气道阻塞性疾病的诊断和用药疗效判断等方面有很大的帮助,在临床上已广泛应用,并发挥着非常重要的作用。但由于支气管舒张试验的结果受诸多因素影响,因此临床应用中需根据具体情况进行分析。
作者 姚婉贞
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2009年第4期243-244,共2页 Chinese Journal of Tuberculosis and Respiratory Diseases
  • 相关文献

参考文献11

  • 1Borg BM, Reid DW, Waiters EH, et al.Bronchodilator reversibility testing: laboratory practices in Australia and New Zealand. Med J Aust, 2004, 180:610-613.
  • 2常春,王筱宏,姚婉贞,柳晓芳,梁岩静.支气管舒张试验药物剂量与间隔时间的临床研究[J].中华结核和呼吸杂志,2008,31(3):191-195. 被引量:16
  • 3Sourk RL, Nugent KM. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis, 1983, 128 : 153-157.
  • 4Lehmann S, Bakke PS, Eide GE, et al. Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist. Pulm Pharmacol Ther, 2006, 19:272-280.
  • 5慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 6Johannessen A, Lehmann S, Omenaas ER, et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med, 2006, 173:1316-1325.
  • 7Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax, 1992, 47:429-436.
  • 8Dompeling E, van Schayck CP, Molema J, et al. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD ; reproducibility and dependence of prebronchodilator FEV1. Eur Respir J, 1992, 5:975-981.
  • 9Anthonisen NR, Lindgren PG, Tashkin DP, et al. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J, 2005, 26:45-51.
  • 10Calverley PM, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax, 2003, 58:659-664.

二级参考文献16

  • 1殷凯生,孙培莉,姚欣.回复《如何判断支气管舒张试验阴性时对诊断支气管哮喘的意义》[J].中华结核和呼吸杂志,2005,28(12):852-852. 被引量:15
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 3Reid DW, Soltani A, Johns DP, et al. Bwnchodilator reversibility in australian adults with chronic obstructive pulmonary disease. Intern Med J,2003,33:572-577.
  • 4Paul O' Byrne. Global Strategy for Asthma Management and Prevention [ DB/OL]. Hamilton.. GINA Executive Committee, 2006 [ 2007-7-11 ] http ://www. ginasthma, com/GuidelineItem. asp.9 intId =60.
  • 5Kesten S, Rebuck AS. Is the short-term response to inhaled betaadrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest, 1994,105 : 1042-1045.
  • 6Chhabra SK. Acute bronchodilator response has limited value in differentiating bronchial asthma from COPD. J Asthma, 2005, 42 : 367 -372.
  • 7GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 8Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 9Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 10冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.

共引文献13197

同被引文献109

引证文献11

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部